I'm glad I'm on this journey." GLP-1 weight loss drugs explained Compare Mounjaro, Wegovy, Zepbound How GLP-1s work for weight loss and diabetes Side effects, safety and monitoring LCM
Animal research published in Endocrinology (2017) demonstrated that 6 weeks of IGF-1 LR3 administration reduced endogenous GH pulse amplitude by 4060%, with recovery taking 34 weeks after discontinuation
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release